Cargando…

Factors affecting uptake of the levonorgestrel-releasing intrauterine device: A mixed-method study of social franchise clients in Nigeria

BACKGROUND: Despite the positive characteristics of the levonorgestrel-releasing intrauterine device (IUD)–a long-acting, highly effective contraceptive with important non-contraceptive attributes–the method has not been widely available in low- and middle-income countries. This study of hormonal IU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunie, Aurélie, Nwala, Anthony Adindu, Stankevitz, Kayla, Lydon, Megan, Danna, Kendal, Afolabi, Kayode, Rademacher, Kate H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480829/ https://www.ncbi.nlm.nih.gov/pubmed/34587200 http://dx.doi.org/10.1371/journal.pone.0257769

Ejemplares similares

Provision of the levonorgestrel intrauterine system in Nigeria: Provider perspectives and service delivery costs
por: Brunie, Aurélie, et al.
Publicado: (2020)

Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia
por: Brunie, Aurélie, et al.
Publicado: (2021)

What are the prospects for the hormonal IUD in the public sector? A mixed-method study of the user population in Zambia
por: Brunie, Aurélie, et al.
Publicado: (2022)

Experiences With the Levonorgestrel Intrauterine System Among Clients, Providers, and Key Opinion Leaders: A Mixed-Methods Study in Nigeria
por: Eva, Gillian, et al.
Publicado: (2018)

What Have We Learned? Implementation of a Shared Learning Agenda and Access Strategy for the Hormonal Intrauterine Device
por: Rademacher, Kate H., et al.
Publicado: (2022)

Use of Objective Structured Clinical Examination (OSCE) in a hybrid digital / in-person training for hormonal IUD in Nigeria: findings and applications of the approach
por: Nwokoma, Ezechukwu, et al.
Publicado: (2023)

Determinants of Method Switching among Social Franchise Clients Who Discontinued the Use of Intrauterine Contraceptive Device
por: Hameed, Waqas, et al.
Publicado: (2015)

Introducing the hormonal Intrauterine Device in Madagascar, Nigeria, and Zambia: results from a pilot study
por: Danna, Kendal, et al.
Publicado: (2022)

Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners
por: Nanda, Geeta, et al.
Publicado: (2018)

Use of a hybrid digital training approach for hormonal IUD providers in Nigeria: results from a mixed method study
por: Little, Kristen M., et al.
Publicado: (2023)

Franchising /
por: Marzorati, Osvaldo J.
Publicado: (2001)

A Global Learning Agenda for the Levonorgestrel Intrauterine System (LNG IUS): Addressing Challenges and Opportunities to Increase Access
por: Rademacher, Kate H., et al.
Publicado: (2018)

Non-contraceptive applications of the levonorgestrel intrauterine system
por: Rodriguez, Maria Isabel, et al.
Publicado: (2010)

Role of the levonorgestrel intrauterine system in effective contraception
por: Attia, Abdelhamid M, et al.
Publicado: (2013)

Restaurant Franchising
por: Khan, Mahmood
Publicado: (2014)

Franchising & Licensing
por: SHERMAN, Andrew
Publicado: (2011)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
por: Vieira da Motta, Marcia, et al.
Publicado: (2013)

The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids
por: Wrona, Wojciech, et al.
Publicado: (2017)

Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women
por: Joo, Jong-Kil, et al.
Publicado: (2021)

User experiences with clinical social franchising: qualitative insights from providers and clients in Ghana and Kenya
por: Sieverding, Maia, et al.
Publicado: (2015)

Test and Prevent: Evaluation of a Pilot Program Linking Clients With Negative HIV Test Results to Pre-exposure Prophylaxis in Zimbabwe
por: Stankevitz, Kayla, et al.
Publicado: (2021)

The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability
por: Beatty, Megan N, et al.
Publicado: (2009)

Abnormal uterine bleeding in midlife: The role of levonorgestrel intrauterine system
por: Shawki, Osama, et al.
Publicado: (2013)

Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases
por: Kim, Mi-La, et al.
Publicado: (2013)

The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
por: Jacobstein, Roy, et al.
Publicado: (2015)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
por: Cheema, Hira Imad, et al.
Publicado: (2017)

Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
por: Lang, Benjamin, et al.
Publicado: (2018)

Rates of IUCD discontinuation and its associated factors among the clients of a social franchising network in Pakistan
por: Azmat, Syed Khurram, et al.
Publicado: (2012)

Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa
por: Pillay, Diantha, et al.
Publicado: (2020)

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
por: Kailasam, Chandra, et al.
Publicado: (2008)

Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding
por: Magon, Navneet, et al.
Publicado: (2013)

The Levonorgestrel Intrauterine System: Reasons to Expand Access to the Public Sector of Africa
por: Hubacher, David
Publicado: (2015)

Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis
por: Sergison, Jill E., et al.
Publicado: (2019)

The levonorgestrel intrauterine device in Australia: analysis of prescribing data 2008–2012
por: Bingham, Amie L., et al.
Publicado: (2018)

Reversible Cerebral Vasoconstriction Syndrome Associated with Levonorgestrel-Releasing Intrauterine System
por: Choi, Sangwon, et al.
Publicado: (2021)

Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: Yang, Siyuan, et al.
Publicado: (2022)

Effects of Levonorgestrel-Releasing Intrauterine Device Therapy on Ovarian Reserve in Menorrhagia
por: Gök, Soner, et al.
Publicado: (2022)

Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
por: Roman, Jose D
Publicado: (2022)

Expanding Access to a New, More Affordable Levonorgestrel Intrauterine System in Kenya: Service Delivery Costs Compared With Other Contraceptive Methods and Perspectives of Key Opinion Leaders
por: Rademacher, Kate H, et al.
Publicado: (2016)

Franchising: pathway to wealth creation
por: Spinelli, Stephen, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_om11t6iuq1o1aj54c9fro9d9j3